---
$id: https://graph.org.ai/products/commodity/51131720
$type: Product
source: UNSPSC
code: "51131720"
title: "Benzarone"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Benzarone

**UNSPSC Code**: 51131720
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thrombolytic agent with the molecular formula C17H14O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 23ZW4BG89C, chemically known as methanone, (2-ethyl-3-benzofuranyl)(4-hydroxyphenyl)- but generally known as benzarone, which bears US NIH Compound Identifier 255968. European Medicines Agency schedules Benzarone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05740MIG. The term BENZARONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). BENZARONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benzarone under HS 29329985 and SITC 51569. As of Q4 2014, BENZARONE remains the US FDA Preferred Term for this commodity. Benzarone bears US NLM identifiers UMLS ID C0053152 and NCI Concept Code C74411. SMILES: O1C(C(C2C1CCCC2)C(=O)C1CCC(O)CC1)CC.

